{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:13:45Z","timestamp":1760188425714},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1988,2,1]],"date-time":"1988-02-01T00:00:00Z","timestamp":570672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1988,2,1]],"date-time":"1988-02-01T00:00:00Z","timestamp":570672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1988,2,1]],"date-time":"1988-02-01T00:00:00Z","timestamp":570672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1988,2,1]],"date-time":"1988-02-01T00:00:00Z","timestamp":570672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1988,2]]},"DOI":"10.1007\/bf00199851","type":"journal-article","created":{"date-parts":[[2004,8,29]],"date-time":"2004-08-29T10:59:46Z","timestamp":1093777186000},"page":"74-82","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions"],"prefix":"10.1007","volume":"26","author":[{"given":"Peter C.","family":"Kohler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn A.","family":"Hank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah Z.","family":"Minkoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Sondel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00199851_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00199863","volume":"21","author":"A Balsari","year":"1986","unstructured":"Balsari A, Marolda R, Gambacorti-Passerini C, Sciorelli G, Tona G, Cosulich E, Taramelli D, Fossati G, Parmiani G, Cascinelli N (1986) Systemic administration of autologous alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung: A phase 1 study. Cancer Immunol Immunother 21:148","journal-title":"Cancer Immunol Immunother"},{"key":"BF00199851_CR2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007890-198502000-00014","volume":"39","author":"PA Beatty","year":"1985","unstructured":"Beatty PA, Greenberg PD, Cheever MA (1985) Adoptive immunotherapy of metastatic B16 melanoma with allogeneic immune cells sensitized to minor histocompatability antigens. Transplantation 39:182","journal-title":"Transplantation"},{"key":"BF00199851_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.151.1.69","volume":"151","author":"MJ Berendt","year":"1980","unstructured":"Berendt MJ, North RJ (1980) T-cell mediated suppression of anti-tumor immunity. J Exp Med 151:69","journal-title":"J Exp Med"},{"key":"BF00199851_CR4","first-page":"29","volume":"3","author":"JL Blank","year":"1985","unstructured":"Blank JL, Hank JA, Molenda J, Borcherding W, Meisner L, Sondel PM (1985) HLA typing and karyotyping of limited number of lymphocytes is facilitated by in vitro expansion with TCGF. Diagn Immunol 3:29","journal-title":"Diagn Immunol"},{"key":"BF00199851_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007890-197309000-00004","volume":"16","author":"MM Bortin","year":"1973","unstructured":"Bortin MM, Rimm AA, Saltzstein EC, Rodey GE (1973) Graft-versus-leukemia: Apparent independent anti-host and anti-leukemia activity of transplanted immunocompetent cells. Transplantation 16:182","journal-title":"Transplantation"},{"key":"BF00199851_CR6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/281490a0","volume":"281","author":"MM Bortin","year":"1979","unstructured":"Bortin MM, Truitt RL, Rimm AA, Bach FH (1979) Graft-versus-leukemia reactivity induced by alloimmunization without augmentation of graft-versus-host reactivity. Nature 281:490","journal-title":"Nature"},{"key":"BF00199851_CR7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4049\/jimmunol.119.2.714","volume":"119","author":"MA Cheever","year":"1977","unstructured":"Cheever MA, Keipf RA, Fefer A (1977) Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro. J Immunol 119:714","journal-title":"J Immunol"},{"key":"BF00199851_CR8","first-page":"113","volume":"3","author":"MA Cheever","year":"1984","unstructured":"Cheever MA, Greenberg PD, Fefer A (1984) Potential for specific cancer therapy with immune T lymphocytes. J Biol Response Mod 3:113","journal-title":"J Biol Response Mod"},{"key":"BF00199851_CR9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ijc.2910340611","volume":"34","author":"MP Colombo","year":"1984","unstructured":"Colombo MP, Ariol I, Parmiani G (1984) Passive adoptive immunotherapy of a low immunogenic BALB\/c lymphoma by systemic alloimmune T lymphocytes. Int J Cancer 34:807","journal-title":"Int J Cancer"},{"key":"BF00199851_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.156.2.385","volume":"156","author":"TJ Eberlein","year":"1982","unstructured":"Eberlein TJ, Rosenstein M, Rosenberg SA (1982) Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in IL-2. J Exp Med 156:385","journal-title":"J Exp Med"},{"key":"BF00199851_CR11","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.123.4.1772","volume":"123","author":"E Fernandez-Cruz","year":"1979","unstructured":"Fernandez-Cruz E, Halliburton B, Feldman JD (1979) In vivo elimination by specific effector cells of an established syngeneic rat Maloney virus-induced sarcoma. J Immunol 123:1772","journal-title":"J Immunol"},{"key":"BF00199851_CR12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.4049\/jimmunol.136.5.1917","volume":"5","author":"PD Greenberg","year":"1986","unstructured":"Greenberg PD (1986) Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: Cytolytic T cells can mediate eradication of disseminated leukemia. J Immunol 5:1917","journal-title":"J Immunol"},{"key":"BF00199851_CR13","first-page":"455","volume":"3","author":"PD Greenberg","year":"1984","unstructured":"Greenberg PD, Cheever MA (1984) Effector mechanisms operative in adoptive therapy of tumor-bearing animals: Implications for the use of interleukin-2. J Biol Response Mod 3:455","journal-title":"J Biol Response Mod"},{"key":"BF00199851_CR14","first-page":"4428","volume":"40","author":"PD Greenberg","year":"1980","unstructured":"Greenberg PD, Cheever MA, Fefer A (1980) Detection of early and delayed anti-tumor effects following curative adoptive chemoimmunotherapy of established leukemia. Cancer Res 40:4428","journal-title":"Cancer Res"},{"key":"BF00199851_CR15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1084\/jem.154.3.952","volume":"154","author":"PD Greenberg","year":"1981","unstructured":"Greenberg PD, Cheever MA, Fefer A (1981) Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+, 2\u2212 lymphocytes. J Exp Med 154:952","journal-title":"J Exp Med"},{"key":"BF00199851_CR16","first-page":"279","volume-title":"Lymphokines, vol 9","author":"EA Grimm","year":"1983","unstructured":"Grimm EA, Rosenberg SA (1983) The human lymphokine-activated killer cell phenomenon. In: Lymphokines, vol 9. Academic Press, New York, p 279"},{"key":"BF00199851_CR17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grimm","year":"1982","unstructured":"Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) The lymphokine activated killer cell phenomenon: Lysis of NK resistant fresh solid tumor cells by IL-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823","journal-title":"J Exp Med"},{"key":"BF00199851_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-3083.1980.tb00051.x","volume":"12","author":"H Inouye","year":"1980","unstructured":"Inouye H, Hank JA, Alter BJ, Bach FH (1980) TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol 12:149","journal-title":"Scand J Immunol"},{"key":"BF00199851_CR19","first-page":"3011","volume":"46","author":"K Itoh","year":"1986","unstructured":"Itoh K, Tilden AB, Balch CM (1986) Interleukin-2 activation of cytotoxic T lymphocytes infiltrating into human metastatic melanomas. Cancer Res 46:3011","journal-title":"Cancer Res"},{"key":"BF00199851_CR20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1097-0142(19850201)55:3<552::AID-CNCR2820550314>3.0.CO;2-2","volume":"55","author":"PC Kohler","year":"1985","unstructured":"Kohler PC, Hank JA, Exten R, Minkoff ZM, Wilson DG, Sondel PM (1985) Clinical response of a patient with diffuse histiocytic lymphoma to adoptive chemoimmunotherapy using cyclophosphamide and alloactivated haploidentical lymphocytes: A case report and phase 1 trial. Cancer 55:552","journal-title":"Cancer"},{"key":"BF00199851_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00200047","volume":"17","author":"B Leshem","year":"1984","unstructured":"Leshem B, Gotsman B, Kedar E (1984) In vitro elicitation of cytotoxic response against a non-immunogenic murine tumor by allosensitization. Cancer Immunol Immunother 17:117","journal-title":"Cancer Immunol Immunother"},{"key":"BF00199851_CR22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(19840215)53:4<896::AID-CNCR2820530414>3.0.CO;2-E","volume":"53","author":"A Mazumder","year":"1984","unstructured":"Mazumder A, Eberling TJ, Grimm EA, Wilson DJ, Keenan AM, Aamodt R, Rosenberg SA (1984) Phase 1 study of adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells. Cancer 53:896","journal-title":"Cancer"},{"key":"BF00199851_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00007890-198304000-00023","volume":"35","author":"RF Meredith","year":"1983","unstructured":"Meredith RF, OKunewick JP (1983) Possibility of graft-versus-leukemia determinants independent of the major histocompatability complex in allogeneic marrow transplantation. Transplantation 35:378","journal-title":"Transplantation"},{"key":"BF00199851_CR24","first-page":"482","volume":"XVIII","author":"RT Mitsuyasu","year":"1985","unstructured":"Mitsuyasu RT, Champlin RE, Ho WG, Winston D, Feig S, Wells J, Terasaki P, Billing R, Weaver M, Gale RP (1985) Prospective randomized controlled trial of ex vivo treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for prevention of graft-versus-host disease: A preliminary report. Transplant Proc XVIII:482","journal-title":"Transplant Proc"},{"key":"BF00199851_CR25","first-page":"974","volume":"42","author":"MB Mokyr","year":"1982","unstructured":"Mokyr MB, Hengst JCD, Dray S (1982) Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors. Cancer Res 42:974","journal-title":"Cancer Res"},{"key":"BF00199851_CR26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.155.4.1063","volume":"155","author":"RJ North","year":"1982","unstructured":"North RJ (1982) Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T-cells. J Exp Med 155:1063","journal-title":"J Exp Med"},{"key":"BF00199851_CR27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4049\/jimmunol.124.1.370","volume":"124","author":"PA Paciucci","year":"1980","unstructured":"Paciucci PA, Macphail S, Zarling JM, Bach FH (1980) Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells. J Immunol 124:370","journal-title":"J Immunol"},{"key":"BF00199851_CR28","first-page":"121","volume":"1","author":"G Parmiani","year":"1985","unstructured":"Parmiani G, Balsari A, Fossati G, Taramelli D, Storchi I, Cascinelli N (1985) Use of allostimulation to generate killer lymphocytes against autologous human melanoma. Cancer Treat Rep 1:121","journal-title":"Cancer Treat Rep"},{"key":"BF00199851_CR29","first-page":"233","volume":"68","author":"SA Rosenberg","year":"1984","unstructured":"Rosenberg SA (1984) The adoptive immunotherapy of cancer: Accomphlishments and prospects. Cancer Treat Rep 68:233","journal-title":"Cancer Treat Rep"},{"key":"BF00199851_CR30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","volume":"313","author":"SA Rosenberg","year":"1985","unstructured":"Rosenberg SA, Lotze MT, Muul LM, Leitmann S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485","journal-title":"N Engl J Med"},{"key":"BF00199851_CR31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","volume":"233","author":"SA Rosenberg","year":"1986","unstructured":"Rosenberg SA, Speiss P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318","journal-title":"Science"},{"key":"BF00199851_CR32","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.136.10.3891","volume":"136","author":"S Shu","year":"1986","unstructured":"Shu S, Chou T, Rosenberg SA (1986) In vitro sensitization and expansion with viable tumor cells and interleukin-2 in the generation of specific therapeutic effector cells. J Immunol 136:3891","journal-title":"J Immunol"},{"key":"BF00199851_CR33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0145-2126(84)90110-3","volume":"8","author":"PM Sondel","year":"1984","unstructured":"Sondel PM, Kohler PC, Hank JA, Bozdech MJ, Lieberman LM, Hong R, Albertini R, Exten RE (1984) The in vivo distribution of indium-111 labeled in vitro alloactivated syngeneic lymphocytes in a patient with relapsed acute myeolmonocytic leukemia: Implications for adoptive chemoimmunotherapy. Leuk Res 8:893","journal-title":"Leuk Res"},{"key":"BF00199851_CR34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4049\/jimmunol.137.2.502","volume":"137","author":"PM Sondel","year":"1986","unstructured":"Sondel PM, Hank JA, Kohler PC, Chen BP, Minkoff DZ, Molenda JA (1986) Destruction of autologous human lymphocytes by interleukin-2 activated cytotoxic cells. J Immunol 137:502","journal-title":"J Immunol"},{"key":"BF00199851_CR35","first-page":"77","volume":"2","author":"J Sosman","year":"1987","unstructured":"Sosman J, Sondel PM (1987) The graft versus leukemia (GVL) effect following bone marrow transplantation (BMT): a review of laboratory and clinical data. Hematol Rev 2:77","journal-title":"Hematol Rev"},{"key":"BF00199851_CR36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM197504172921605","volume":"292","author":"ED Thomas","year":"1975","unstructured":"Thomas ED, Storb R, Clift RA, Fefer A (1975) Bone marrow transplantation. N Engl J Med 292:832","journal-title":"N Engl J Med"},{"key":"BF00199851_CR37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner D, Storb R (1979) Antileukemia effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 300:1068","journal-title":"N Engl J Med"},{"key":"BF00199851_CR38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/274269a0","volume":"274","author":"JM Zarling","year":"1978","unstructured":"Zarling JM, Robins IA, Raich PC, Bach FH, Bach ML (1978) Generation of cytotoxic T lymphocytes to autologous human leukemia cells by sensitization to pooled allogeneic normal cells. Nature 274:269","journal-title":"Nature"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00199851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00199851\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00199851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00199851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T07:46:06Z","timestamp":1682754366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00199851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,2]]}},"alternative-id":["BF00199851"],"URL":"https:\/\/doi.org\/10.1007\/bf00199851","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,2]]},"assertion":[{"value":"28 January 1987","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 1987","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}